Registre de correu electrònic: Brief Report: SWOG S1400D (), a
Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in
Previously-treated Patients with Fibroblast Growth Factor Pathway-Activated
Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)